Comparison Study of the Effect of Erlotinib as a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy. IHJPAS [Internet]. 2018 Nov. 19 [cited 2024 May 7];31(3):63-9. Available from: https://jih.uobaghdad.edu.iq/index.php/j/article/view/2011